Trial data support 3 shorter regimens for drug-resistant TB
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New England Journal of Medicine. The phase 3 trial, conducted by an international team of researchers with the endTB (Evaluating Newly Approved Drugs for Multidrug-Resistant Tuberculosis) project, compared outcomes in patients who received five